TMDX241220P45000
- 0.82
- 0.000.00%
TransMedics Newsroom
Needham Downgrades TransMedics(TMDX.US) to Hold Rating
TransMedics Group Price Target Maintained With a $109.00/Share by Needham
TransMedics Group (TMDX) Was Downgraded to a Hold Rating at Needham
Express News | Transmedics Group Inc : Needham Cuts to Hold From Buy
Jim Cramer on TransMedics Group, Inc. (TMDX): 'I Don't Know How You Can Really Make A Lot Of Money In That Business, Frankly'
Looking Into TransMedics Gr's Recent Short Interest
Oppenheimer Maintains TransMedics(TMDX.US) With Buy Rating, Cuts Target Price to $125
TransMedics Group (TMDX) Gets a Buy From Oppenheimer
TransMedics Group Is Maintained at Buy by Canaccord Genuity
CCORF Maintains TransMedics(TMDX.US) With Buy Rating, Cuts Target Price to $104
Jim Cramer Likes Devon Energy, But Calls Another Stock 'Far Superior'
Piper Sandler Maintains TransMedics(TMDX.US) With Buy Rating, Cuts Target Price to $110
Express News | Transmedics Group Inc : Canaccord Genuity Cuts Target Price to $104 From $109
TransMedics to Participate in the Piper Sandler 36th Annual Healthcare Conference
TransMedics Gr Analyst Ratings
TD Cowen Maintains TransMedics(TMDX.US) With Buy Rating, Cuts Target Price to $120
Positive Growth in TransMedics Group Amid Rising Transplant Volumes and Market Alignment
TransMedics Group (NASDAQ:TMDX) Seems To Use Debt Quite Sensibly
Down 52%, Is TransMedics Stock a Buy on the Dip?
Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation Into TransMedics Group, Inc. (NASDAQ: TMDX)